The Physician-Pharma Relationship. PharmedOut.org Georgetown University Medical Center January 2008. The Physician-Pharma Relationship. Is very old and very close But are the goals of pharmaceutical companies and medicine the same? . Promotion includes. Detailing
Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author.While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server.
Georgetown University Medical Center
IMS national sales perspectives. IMS Health. 2007 Mar. Table
West D. Changing lanes. Pharm Exec. 2005 May;25(5):154-162. Full text
*NIH summary of the FY 2008 president’s budget, 2007 Feb 5. Summary
**Summary of FDA’s FY 2008 budget. Summary
*Ma J et al. Clin Ther 2003;25(5):1503-17. Abstract
*Chren MM and Landefeld CSl. JAMA 1994 Mar 2;271(9):684-9. Abstract
Lurie N et al. J Gen Int Med 1990;5(3):240-243. Abstract
Wazana A. JAMA 2000 Jan 19;283(3):373-80. Abstract
**Sigworth SK et al. JAMA. 2001 Sept 5;286(9):1024-5. Abstract
McKinney WP et al. JAMA 1990 Oct 3;264(13):1693-7. Abstract
*Goldberg M et. al. Pharm Exec. 2004 Jan 1;24:40-5. Abstract
*Greene JA. Ann Int Med. 2007 May 15;146:742-8. Full text
**Steinbrook R. NEJM. 2006 Jun 29;354(26):2745-7. Abstract
Herskovits B. Pharm Exec Direct. 2006 Jul 19. Full text
Musacchio RA and Hunkler RJ. Pharm Exec 2006 May 1. Full text
*Goldberg M and Davenport B. Pharm Exec. 2005 Jan 1;25(1): 70. Full text
**Niles S. Med Ad News. 2005 May;24(5):1-4.
*Fugh-Berman A and Ahari S. PLoS Med. 2007 Apr 24;4(4):e150. Full text
Elliott C. Atlantic Monthly. 2006 Apr;297(3):82-93. Full text
Prounis C. Best foot forward. Communique, vol 7. Full text(also
Start treatment immediately
Test tolerance to a new drug
Reduce the total cost of a Rx
Provide free medication to those who can’t afford it
Increases “new starts” on a new drug
Encourages switches from other drugs
Patients usually stay on the sampled drug
Increases prescriptions of the most expensive, most promoted drugs
“…the manufacturer needs to figure out the right amount of samples the rep has to drop off in order to maximize the number of paid prescriptions written.”
Tsang J and Rudychev I. Medical Marketing & Media. 2006 Feb;41(2):52-8.
“Nearly 30 percent of physicians who attend association meetings refuse to see reps in their office…a no-see strategy is critical for companies to overcome”
Rehal D. Successful Product Manager’s Handbook. Pharm Exec. 2007 Mar 1;7:8-15. Full text
ACCME Annual Report Data 2006, Table 7. 2007 Jul 6. Report
Fugh-Berman A, Alladin K, Chow J. PLoS Med. 2006;3(6):e130. Full text
Paul CM. Medical Marketing & Media. 2006 Dec;41(12):60-2. Full text
Edwards J. Brandweek. 2005 Feb 7; ;46(6):24-6.
*Robins R. Successful Product Manager’s Handbook. Pharm Exec 2007 Mar 1;7:38-41.
**Niles S. Med Ad News 2004 Mar;23(3):1
Educational materials, news, resources, film clips, slideshows, articles, book list
Funded by the Attorney General Consumer and Prescriber Education grant program, created as part of a 2004 settlement between Warner-Lambert, a division of Pfizer, Inc., and the Attorneys General of 50 States and D.C., to settle allegations that Warner-Lambert conducted an unlawful marketing campaign for the drug Neurontin® (gabapentin). Contact us at http://www.pharmedout.org or 202-687-1191.